Medroxyprogesterone improves nocturnal breathing in postmenopausal women with chronic obstructive pulmonary disease

BACKGROUND: Progestins as respiratory stimulants in chronic obstructive pulmonary disease (COPD) have been investigated in males and during wakefulness. However, sleep and gender may influence therapeutic responses. We investigated the effects of a 2-week medroxyprogesterone acetate (MPA) therapy on...

Descripción completa

Detalles Bibliográficos
Autores principales: Saaresranta, Tarja, Aittokallio, Tero, Utriainen, Karri, Polo, Olli
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1079947/
https://www.ncbi.nlm.nih.gov/pubmed/15807890
http://dx.doi.org/10.1186/1465-9921-6-28

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1079947/
https://www.ncbi.nlm.nih.gov/pubmed/15807890
http://dx.doi.org/10.1186/1465-9921-6-28

Ejemplares similares